ASBP Insider Trading Activity and SEC Form 4 Filings
ASBP insider trading summary
No open-market insider purchases or sales of Aspire Biopharma Holdings, Inc. (ASBP) have been reported on SEC Form 4 in the past 12 months.
Latest ASBP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 5, 2025 | Donald G. Fell | Director | Buy | $4K (10,500 @ $0.39) |
| Jun 4, 2025 | Donald G. Fell | Director | Buy | $4K (9,500 @ $0.39) |
| Sep 30, 2005 | Christopher H Lute | Director | Buy | $21K (1,000 @ $20.75) |
| Jul 1, 2005 | Christopher H Lute | Director | Buy | $2K (88 @ $22.40) |
| Jun 7, 2005 | William J Burke | Director | Sell | $2K (100 @ $22.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.